Facebook tracking pixel
S10.AI
ICD-10-CM · L70.0GeneralSystemic

Acne

Find comprehensive information on Acne (Acne Vulgaris), including clinical documentation for healthcare professionals, medical coding insights for accurate billing (ICD-10 codes for Acne), and resources for diagnosing and managing various forms like Cystic Acne and Acné Excoriée. Learn about effective treatments, symptoms, and best practices for documenting Acne in medical records. This resource is designed to support accurate clinical documentation and optimized medical coding related to Acne.

Also known as
Acne VulgarisCystic AcneAcné Excoriée
Definition

Inflammatory skin condition with pimples, blackheads, and whiteheads.

Clinical signs

Comedones, papules, pustules, nodules, cysts, and scarring.

Common settings

Face, back, chest, shoulders. Treated by dermatologists, primary care.

Related Codes

ICD-10 Code Families

Complete code families applicable to L70.0

L70-L70
Acne
L73-L73
Other follicular disorders
L98-L98
Other disorders of skin and subcutaneous tissue
F45-F45
Somatoform disorders
Code Comparison

When to use each related code

DescriptionWhen to use
Inflammatory skin condition with pimples, blackheads, etc.Use for inflammatory lesions like papules, pustules, nodules primarily on the face, back, or chest.
Chronic inflammatory skin condition causing raised, red, scaly plaques.Use for well-defined, erythematous plaques with silvery scales, especially on extensor surfaces and scalp. Consider comorbidities like psoriatic arthritis.
Common, chronic skin rash involving itchy, inflamed skin.Use for intensely itchy, dry, or scaly skin, often with redness and excoriations. Consider triggers like allergies or irritants.
Documentation

Best-practice checklist

  • Document acne lesion morphology (e.g., comedones, papules, pustules, nodules)
  • Record acne distribution (e.g., face, back, chest)
  • Note acne severity (e.g., mild, moderate, severe)
  • Document any associated symptoms (e.g., pain, scarring)
  • Include relevant medical history (e.g., prior treatments, family history)
Coding & Audit Risks

Common pitfalls to avoid

Unspecified Acne Type

Coding acne without specifying type (e.g., vulgaris, cystic) may lead to claim rejection for insufficient documentation. Impacts accurate severity reflection.

Acne Scar Coding

Incorrectly coding acne scarring with active acne or vice versa. Distinct codes are required based on the condition's presentation.

Medical Necessity for Treatment

Lack of documentation supporting medical necessity for acne treatments (e.g., isotretinoin) can raise audit flags and denial risks. Document severity and prior treatments.

Mitigation

Best-practice tips

  • 01Wash face twice daily with mild cleanser. Code: L70.0
  • 02Avoid picking or squeezing. Document inflammation, scarring. Code: L70.1
  • 03Topical retinoids. CDI: Monitor efficacy, adjust dosage. Code: L70.5
  • 04Oral antibiotics for moderate to severe acne. Compliance: Patient education. Code: L70.8
  • 05Consider isotretinoin for severe cystic acne. CDI: Pregnancy test, consent. Code: L70.9
Clinical Decision Support

Step-by-step checklist

  1. 1

    Confirm acne type (e.g., comedonal, inflammatory, nodular)

  2. 2

    Document lesion morphology, location, and severity

  3. 3

    Assess for scarring or hyperpigmentation

  4. 4

    Rule out rosacea, folliculitis, perioral dermatitis

Documentation Template

Ready-to-paste narrative

Patient presents with acne vulgaris, characterized by comedones, papules, pustules, and nodules consistent with inflammatory acne.  The patient reports a history of acne breakouts, with current exacerbation impacting the face, chest, and back.  Severity is assessed as moderate based on lesion count and distribution.  Differential diagnoses considered include rosacea and folliculitis.  The patient denies any known allergies.  Family history is positive for acne.  Current skincare regimen includes over-the-counter benzoyl peroxide wash.  Treatment plan includes initiating topical retinoid therapy with tretinoin cream 0.025% applied nightly.  Patient education provided on proper application, potential side effects such as dryness and irritation, and the importance of sun protection.  Discussed the potential for oral antibiotic therapy if topical treatment is insufficient.  Follow-up appointment scheduled in 4 weeks to assess treatment response and adjust management as needed.  ICD-10 code L70.0 assigned for acne vulgaris.  Counseling provided regarding acne scar prevention and treatment options if scarring develops.  Patient acknowledges understanding of the treatment plan and potential outcomes.
FAQs

Common questions and answers

What are the most effective evidence-based treatment strategies for managing moderate to severe acne vulgaris in adult patients with sensitive skin?+

Managing moderate to severe acne vulgaris in adult patients with sensitive skin requires a multifaceted approach tailored to individual needs. Topical retinoids like tretinoin are considered first-line therapy, but their irritancy can be challenging. Strategies to mitigate this include starting with a low concentration (0.025%), applying on alternate nights, or using a "sandwich technique" where a moisturizer is applied before and after the retinoid. Combination therapy with topical antibiotics like clindamycin can enhance efficacy and reduce inflammation. For patients with persistent or recalcitrant acne, oral antibiotics such as doxycycline may be considered for short courses. However, the rise of antibiotic resistance necessitates cautious use. Hormonal therapies like combined oral contraceptives can be beneficial for women with hormonally influenced acne. Isotretinoin remains the most effective treatment for severe nodulocystic acne, but its teratogenic potential necessitates careful patient selection and monitoring. Explore how incorporating anti-inflammatory agents like azelaic acid or niacinamide can further support treatment and minimize irritation in sensitive skin. Consider implementing a comprehensive skincare routine including gentle cleansers and non-comedogenic moisturizers to optimize outcomes. Learn more about emerging therapies like light and laser treatments for acne.

How can I differentiate between acne excoriée and other forms of acne, and what are the best psychological and dermatological management strategies?+

Acne excoriée, also known as skin picking disorder, presents as inflamed lesions and scars resulting from compulsive picking or scratching, often triggered by minor acne imperfections. Distinguishing it from other acne types involves assessing the patient's history and observing the characteristic pattern of excoriations, often concentrated in accessible areas. While primary acne lesions might be present, the dominant clinical feature is the self-inflicted damage. Management necessitates a combined psychological and dermatological approach. Cognitive behavioral therapy (CBT) and habit reversal training (HRT) are effective psychological interventions, helping patients identify triggers, develop coping mechanisms, and break the picking cycle. Dermatological management addresses underlying inflammation and promotes skin healing. Topical retinoids and antibiotics can help reduce initial acne lesions, while topical corticosteroids may be used judiciously for short periods to alleviate inflammation from picking. Consider implementing mindfulness techniques and stress management strategies to support psychological well-being. Explore how collaboration with mental health professionals can optimize outcomes in patients with acne excoriée.

What are the key clinical features and diagnostic considerations for differentiating cystic acne from other inflammatory skin conditions, and what are the latest treatment guidelines for optimal management?+

Cystic acne is characterized by deep, inflamed nodules and cysts that can cause significant pain, scarring, and psychological distress. Differentiating it from other inflammatory skin conditions like hidradenitis suppurativa or rosacea involves careful evaluation of lesion morphology, distribution, and associated symptoms. Cystic acne lesions tend to be larger, more fluctuant, and deeper than typical inflammatory acne papules or pustules. They often occur on the face, chest, and back. Diagnosis is primarily clinical, based on visual inspection. Biopsies are rarely necessary. The latest treatment guidelines emphasize a multi-pronged approach. Topical therapies alone are often insufficient for cystic acne. Oral isotretinoin remains the gold standard for severe cases, offering significant long-term remission. Oral antibiotics like doxycycline or minocycline can be used as adjunctive therapy or for less severe cases. However, prolonged antibiotic use should be avoided due to the risk of antibiotic resistance. Hormonal therapies, such as combined oral contraceptives or spironolactone, can be beneficial for women with hormonally driven cystic acne. Explore how intralesional corticosteroid injections can be used to rapidly reduce inflammation in individual cystic lesions. Learn more about combining oral therapies with topical retinoids and benzoyl peroxide to optimize efficacy and minimize the risk of relapse.

Clinical accuracy: This information is provided for documentation and coding guidance and should not replace professional medical judgment.

Coding standard: ICD-10-CM, current FY guidelines.